[go: up one dir, main page]

WO2008141751A3 - Compositions pharmaceutiques comprenant de l'oxcarbazépine - Google Patents

Compositions pharmaceutiques comprenant de l'oxcarbazépine Download PDF

Info

Publication number
WO2008141751A3
WO2008141751A3 PCT/EP2008/003814 EP2008003814W WO2008141751A3 WO 2008141751 A3 WO2008141751 A3 WO 2008141751A3 EP 2008003814 W EP2008003814 W EP 2008003814W WO 2008141751 A3 WO2008141751 A3 WO 2008141751A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical compositions
oxcarbazepine
less
particle size
relates
Prior art date
Application number
PCT/EP2008/003814
Other languages
English (en)
Other versions
WO2008141751A2 (fr
Inventor
Satish G Dhonde
Ganesh V Gat
Jawed Hussain
Original Assignee
Ratiopharm Gmbh
Satish G Dhonde
Ganesh V Gat
Jawed Hussain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ratiopharm Gmbh, Satish G Dhonde, Ganesh V Gat, Jawed Hussain filed Critical Ratiopharm Gmbh
Priority to EP08758478A priority Critical patent/EP2146699A2/fr
Publication of WO2008141751A2 publication Critical patent/WO2008141751A2/fr
Publication of WO2008141751A3 publication Critical patent/WO2008141751A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne les compositions pharmaceutiques contenant de l'oxcarbazépine avec une taille médiane de particule d'environ 2 μm ou moins.
PCT/EP2008/003814 2007-05-23 2008-05-13 Compositions pharmaceutiques comprenant de l'oxcarbazépine WO2008141751A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP08758478A EP2146699A2 (fr) 2007-05-23 2008-05-13 Compositions pharmaceutiques comprenant de l'oxcarbazépine

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1078/CHE/2007 2007-05-23
IN1078CH2007 2007-05-23

Publications (2)

Publication Number Publication Date
WO2008141751A2 WO2008141751A2 (fr) 2008-11-27
WO2008141751A3 true WO2008141751A3 (fr) 2009-07-16

Family

ID=39679291

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/003814 WO2008141751A2 (fr) 2007-05-23 2008-05-13 Compositions pharmaceutiques comprenant de l'oxcarbazépine

Country Status (2)

Country Link
EP (1) EP2146699A2 (fr)
WO (1) WO2008141751A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2906107C (fr) * 2013-03-15 2021-08-24 Aprecia Pharmaceuticals Company Forme posologique d'oxcarbazepine a dispersion rapide
WO2015063670A1 (fr) * 2013-10-30 2015-05-07 Wockhardt Limited Composition orale solide a liberation modifiee comprenant de l'oxcarbazepine ou un sel pharmaceutiquement acceptable de ce compose

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998035681A1 (fr) * 1997-02-14 1998-08-20 Novartis Ag Comprimes d'oxacarbazepine enrobes par pelliculage
WO2002094774A2 (fr) * 2001-05-18 2002-11-28 Ranbaxy Laboratories Limited Formes galeniques d'oxcarbazepine
EP1815849A1 (fr) * 2006-01-31 2007-08-08 Teva Pharmaceutical Industries Ltd Formulation pharmaceutique d'oxcarbazepine, et sa méthode de fabrication, caractérisée en ce que l'oxcarbazepine a une distribution de la taille des particules qui est large et multi-modale

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998035681A1 (fr) * 1997-02-14 1998-08-20 Novartis Ag Comprimes d'oxacarbazepine enrobes par pelliculage
WO2002094774A2 (fr) * 2001-05-18 2002-11-28 Ranbaxy Laboratories Limited Formes galeniques d'oxcarbazepine
EP1815849A1 (fr) * 2006-01-31 2007-08-08 Teva Pharmaceutical Industries Ltd Formulation pharmaceutique d'oxcarbazepine, et sa méthode de fabrication, caractérisée en ce que l'oxcarbazepine a une distribution de la taille des particules qui est large et multi-modale

Also Published As

Publication number Publication date
EP2146699A2 (fr) 2010-01-27
WO2008141751A2 (fr) 2008-11-27

Similar Documents

Publication Publication Date Title
WO2008064353A3 (fr) Analogues 4,5-époxy-morphinanium saturé en position 7 et 8
WO2010068471A3 (fr) Compositions d'hygiène bucco-dentaire pour dents sensibles
WO2011077043A3 (fr) Derives phenoliques, et leur utilisation pharmaceutique ou cosmetique
WO2007101551A3 (fr) Complexes phospholipidiques de curcumine présentant une biodisponibilité améliorée
WO2010069532A8 (fr) Anticorps dirigés contre l'angiopoïétine 2 humaine
WO2011069063A3 (fr) Composés multicycliques et leurs procédés d'utilisation
WO2012042371A3 (fr) Composition pharmaceutique
IL196226A0 (en) Phosphonate and phosphinate compounds and pharmaceutical compositions containing the same
WO2011107186A3 (fr) Composés pour dispositifs électroniques
IL218130A (en) Compounds containing pyrazole that are administered to bicyclo [0.1.3] hexane and pharmaceutical preparations containing them
WO2012066308A3 (fr) Compositions
EP4537849A3 (fr) Compositions pharmaceutiques contenant des anatoxines a et b de clostridium difficile
PL2083809T3 (pl) Kompozycja dietetyczna lub farmaceutyczna zawierająca tricykliczne diterpeny do leczenia depresji
WO2010054286A3 (fr) Composés d'hydroxyphénylamine substitués
WO2010122332A3 (fr) Composition contenant de la gomme xanthane et une matière particulaire apte à gonfler, et ses utilisations
WO2007075381A3 (fr) Compositions pharmaceutiques d'ilaprazole
WO2009102707A3 (fr) Oxazaphosphorines substituées
ME01542B (me) Antikancerozno jedinjenje i farmaceutska kompozicija koja ga sadrži
WO2012075015A3 (fr) Compositions pharmaceutiques orales de métronidazole
WO2008154234A3 (fr) Formulation à libération prolongée de névirapine
WO2012025828A3 (fr) Stévia en poudre superfine
WO2007128639A3 (fr) Nouveaux polymères cationiques à modifications hydrophobes et préparations de soins personnels les comprenant
WO2008081268A3 (fr) Compositions pharmaceutiques d'entacapone
TWI340042B (en) Preparation of anti-dandruff bioactives from sapindus mukorossi and extended products containing the bioactives.
WO2008141751A3 (fr) Compositions pharmaceutiques comprenant de l'oxcarbazépine

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08758478

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2008758478

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE